KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway

被引：0
|
作者：
Xiaomin Chen
Tiange Lu
Yiqing Cai
Yang Han
Mengfei Ding
Yurou Chu
Xiangxiang Zhou
Xin Wang
机构：
[1] Shandong University,Department of Hematology, Shandong Provincial Hospital
[2] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Hematology
[3] Shandong Provincial Engineering Research Center of Lymphoma,National Clinical Research Center for Hematologic Diseases
[4] Branch of National Clinical Research Center for Hematologic Diseases,undefined
[5] The First Affiliated Hospital of Soochow University,undefined
来源：
Cellular & Molecular Biology Letters | / 28卷
关键词：
Diffuse large B-cell lymphoma; -methyladenosine; KIAA1429; YTHDF2; CHST11; Hippo–YAP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 23 条
  • [1] KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway
    Chen, Xiaomin
    Lu, Tiange
    Cai, Yiqing
    Han, Yang
    Ding, Mengfei
    Chu, Yurou
    Zhou, Xiangxiang
    Wang, Xin
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2023, 28 (01)
  • [2] Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification
    Chen, Xiaoqing
    Fan, Renxiu
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2024, 53 (04) : 266 - 274
  • [3] Identification of m6a Methyltransferase KIAA1429 As a Potential Prognostic Biomarker in Diffuse Large B-Cell Lymphoma
    Chen, Xiaomin
    Ren, Shuai
    Ding, Mengfei
    Cai, Yiqing
    Hu, Shunfeng
    Zhao, Yi
    Han, Yang
    Zhou, Xiangxiang
    Wang, Xin
    BLOOD, 2020, 136
  • [4] The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1
    Guo, Shuangshuang
    Zhao, Chunling
    Fang, Liang
    Xu, Wenzhong
    Dalia, Samir
    Glass, Jon
    Shikama, Naoto
    Zhang, Zhiye
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (14)
  • [5] GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway
    Wang, Zeyuan
    Ran, Xianting
    Qian, Siyu
    Hou, Huting
    Dong, Meng
    Wu, Shaoxuan
    Ding, Mengjie
    Zhang, Yue
    Zhang, Xudong
    Zhang, Mingzhi
    Chen, Qingjiang
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2021, 710
  • [6] CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin
    Cheng, Ruiduo
    Dai, Ying
    Wang, Qiwei
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 689 - 695
  • [7] M6A modification-mediated LIMA1 promotes the progression of hepatocellular carcinoma through the wnt-βcatenin/Hippo pathway
    Zhang, Chao
    Wang, Xiaoxiao
    Song, Huangqin
    Yuan, Junlong
    Zhang, Xiaomin
    Yuan, Yiran
    Wang, Zhuangqiang
    Lei, Zhang
    He, Jiefeng
    CELL BIOLOGY AND TOXICOLOGY, 2024, 41 (01)
  • [8] METTL3-mediated m6A methylation of C1qA regulates the Rituximab resistance of diffuse large B-cell lymphoma cells
    Junping Li
    Zhigang Zhu
    Yuan Zhu
    Jinqing Li
    Kangbao Li
    Weijie Zhong
    Cell Death Discovery, 9
  • [9] ATF6 activation promotes tumorigenesis and drug resistance in diffuse large B-cell lymphoma (DLBCL) by regulating the mTOR/S6K signaling pathway
    Shuang Su
    Lili Wu
    Chen Huang
    Cuiying He
    Lianjing Wang
    Weijing Li
    Wei Liu
    Lihong Liu
    Discover Oncology, 16 (1)
  • [10] METTL3-mediated m6A methylation of C1qA regulates the Rituximab resistance of diffuse large B-cell lymphoma cells
    Li, Junping
    Zhu, Zhigang
    Zhu, Yuan
    Li, Jinqing
    Li, Kangbao
    Zhong, Weijie
    CELL DEATH DISCOVERY, 2023, 9 (01)
123